Exploring the validity of estimating EQ-5D and SF-6D utility values from the health assessment questionnaire in patients with inflammatory arthritis

被引：0
|
作者：
Mark J Harrison
Mark Lunt
Suzanne MM Verstappen
Kath D Watson
Nick J Bansback
Deborah PM Symmons
机构：
[1] The University of Manchester,The arc Epidemiology Unit
[2] St. Paulșs Hospital,Centre for Health Evaluation and Outcome Sciences
来源：
Health and Quality of Life Outcomes | / 8卷
关键词：
Utility Score; Health Assessment Questionnaire; Minimum Important Difference; Health Assessment Questionnaire Disability Index; Health Assessment Questionnaire Score;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Patients' preferences and health utility assessment with SF-6D and EQ-5D in patients with chronic hepatitis C treated with sofosbuvir regimens
    Stepanova, M.
    Nader, F.
    Cure, S.
    Bourhis, F.
    Hunt, S.
    Younossi, Z. M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 40 (06) : 676 - 685
  • [22] Understanding the Relationship between the EQ-5D, SF-6D, HAQ and Disease Activity in Inflammatory Arthritis
    Roisin Adams
    Cathal Walsh
    Douglas Veale
    Barry Bresnihan
    Oliver FitzGerald
    Michael Barry
    PharmacoEconomics, 2010, 28 : 477 - 487
  • [23] Understanding the Relationship between the EQ-5D, SF-6D, HAQ and Disease Activity in Inflammatory Arthritis
    Adams, Roisin
    Walsh, Cathal
    Veale, Douglas
    Bresnihan, Barry
    FitzGerald, Oliver
    Barry, Michael
    PHARMACOECONOMICS, 2010, 28 (06) : 477 - 487
  • [24] Predicting EQ-5D-US and SF-6D societal health state values from the Osteoporosis Assessment Questionnaire
    McDonough, C. M.
    Grove, M. R.
    Elledge, A. D.
    Tosteson, A. N. A.
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 (02) : 723 - 732
  • [25] Predicting EQ-5D-US and SF-6D societal health state values from the Osteoporosis Assessment Questionnaire
    C. M. McDonough
    M. R. Grove
    A. D. Elledge
    A. N. A. Tosteson
    Osteoporosis International, 2012, 23 : 723 - 732
  • [26] Measuring health-related utility: Why the disparity between EQ-5D and SF-6D?
    Bryan S.
    Longworth L.
    The European Journal of Health Economics, 2005, 6 (3) : 253 - 260
  • [27] An empirical evaluation of the SF-12, SF-6D, EQ-5D and Michigan Hand Outcome Questionnaire in patients with rheumatoid arthritis of the hand
    Melina Dritsaki
    Stavros Petrou
    Mark Williams
    Sarah E. Lamb
    Health and Quality of Life Outcomes, 15
  • [28] Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease
    Henk F van Stel
    Erik Buskens
    Health and Quality of Life Outcomes, 4
  • [29] An empirical evaluation of the SF-12, SF-6D, EQ-5D and Michigan Hand Outcome Questionnaire in patients with rheumatoid arthritis of the hand
    Dritsaki, Melina
    Petrou, Stavros
    Williams, Mark
    Lamb, Sarah E.
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2017, 15
  • [30] Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease
    van Stel, Henk F.
    Buskens, Erik
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2006, 4 (1)
12345